Executive record

Stephen F. Betz, Ph.D.

Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:stephen-f-betz-ph-dVersion: public-0As of: 2026-09-29

Not yet claimed7 published Claims2 sources
  • Executive

Key Claims

Biography

Co-founder serving as Chief Scientific Officer since October 2021; previously Director of Endocrinology and Metabolism at Neurocrine Biosciences working on GnRH receptor antagonists; earlier experience at GeneFormatics and Abbott Laboratories in pharmaceutical discovery and structure-guided drug design.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Scientific Officer · Crinetics Pharmaceuticals, Inc.
  2. 2026 to end not publishedExecutive title: Chief Scientific Officer · Organization not publishedCRNX DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. CRNX DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Crinetics Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Scientific Officer · Claim reviewed: May 16, 2026
    • Other Company Role: Stephen F. Betz, Ph.D. is also linked to Radionetics Oncology as Member of scientific advisory board. · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026

    Supports 1 claim
    • Professional Role: Chief Scientific Officer at Crinetics Pharmaceuticals, Inc. · Claim reviewed: Sep 6, 2026